Watson Pharmaceuticals (WPI) 58.34 -0.26

Watson Pharmaceuticals, Inc.
(WPI) 58.34 -0.26

Last Trade:	57.99	Day Range:	57.72 - 58.55
Trade Time:	04:02PM	52wk Range:	53.73 - 73.3499
Prev. Close:	58.25	Market Cap:	7.37B
Open:	57.83	Div Yield:	0
Volume:	1314907	PE:	400
EPS:	1.46

The Latest On WPI

Watson Confirms Beyaz Patent Challenge 2/10/12 4:07pm

Watson Reaches Settlement With Janssen Pharmaceuticals Over ORTHO TRI-CYCLEN LO 2/8/12 8:31am

Acorda Therapeutics Announces Launch of Authorized Generic Version of ZANAFLEX CAPSULES® 2/6/12 4:15pm

Watson Provides Update on Generic Lidoderm Application 2/3/12 9:26am

Watson Announces New Jersey-Based Global R&D Technology Center 1/30/12 9:25am

Watson Reaches Settlement with Mallinckrodt Over Exalgo 1/26/12 4:00pm

UPDATE: Watson Confirms Court Stays Preliminary Injunction; Permits Launch of Generic LOVENOX 1/26/12 11:29am

Jefferies Cuts Target to $60 on Watson Pharmaceuticals 1/25/12 12:44pm

Jefferies Lowers PT on Watson Pharmaceuticals to $60 1/25/12 10:02am

Benzinga's Top Upgrades 1/25/12 7:38am

Financial Breakfast: Morning News Summary for January 25, 2012 1/25/12 7:26am

UPDATE: Morgan Stanley Upgrades Watson Pharmaceuticals to Overweight, Lowers PT to $65 1/25/12 7:10am

Watson Confirms Beyaz Patent Challenge 2/10/12

Watson Reaches Settlement With Janssen Pharmaceuticals Over ORTHO TRI-CYCLEN LO 2/8/12

Acorda Therapeutics Announces Launch of Authorized Generic Version of ZANAFLEX CAPSULES® 2/6/12

Watson Provides Update on Generic Lidoderm Application 2/3/12

Watson Announces New Jersey-Based Global R&D Technology Center 1/30/12

Watson Reaches Settlement with Mallinckrodt Over Exalgo 1/26/12

UPDATE: Watson Confirms Court Stays Preliminary Injunction; Permits Launch of Generic LOVENOX 1/26/12

Jefferies Cuts Target to $60 on Watson Pharmaceuticals 1/25/12

Jefferies Lowers PT on Watson Pharmaceuticals to $60 1/25/12

Benzinga's Top Upgrades 1/25/12

Financial Breakfast: Morning News Summary for January 25, 2012 1/25/12

UPDATE: Morgan Stanley Upgrades Watson Pharmaceuticals to Overweight, Lowers PT to $65 1/25/12

Financial Breakfast: Morning News Summary for January 25, 2012 1/25/12

Benzinga's M&A Chatter for Tuesday January 24, 2012 1/24/12

Financial Breakfast: Morning News Summary for January 24, 2012 1/24/12

Jefferies Reiterates Hold, $70 PT On Watson Pharmaceuticals 12/20/11

Is Endo Pharmaceuticals Going to Seize Market Share? 12/12/11

Are You Guaranteed Profits if These Rumors are True? 12/9/11

Financial Breakfast: Morning News Summary for December 8, 2011 12/8/11

After Today, Plan B Emergency Contraceptive Pill May Appear On Shelves Next to Aspirin 12/7/11

Financial Breakfast: Morning News Summary for November 30, 2011 11/30/11

Fast Money Picks For November 8th (GM, KEG, RIG, PLCM, WPI) 11/7/11

How to Play It: Pfizer's Lipitor to Go Generic At The End of Month 11/7/11

Earnings Expectations for the Week of October 31 10/30/11

Jefferies Cuts Target to $60 on Watson Pharmaceuticals 1/25/12

Jefferies Lowers PT on Watson Pharmaceuticals to $60 1/25/12

Benzinga's Top Upgrades 1/25/12

Financial Breakfast: Morning News Summary for January 25, 2012 1/25/12

UPDATE: Morgan Stanley Upgrades Watson Pharmaceuticals to Overweight, Lowers PT to $65 1/25/12

Morgan Stanley Upgrades Watson Pharmaceuticals to Overweight 1/25/12

Jefferies Says Watson Pharmaceuticals 2012 Guidance Light but Should be Beatable 1/24/12

Morgan Stanley Remains Equal-Weight on Watson Pharmaceuticals 1/24/12

Financial Breakfast: Morning News Summary for January 24, 2012 1/24/12

UPDATE: Piper Jaffray Lowers Watson Pharmaceuticals PT 1/23/12

Piper Jaffray Lowers PT on Watson Pharmaceuticals to $73 1/23/12

Piper Jaffray Maintains Overweight, PT of $78 on Watson Pharmaceuticals 1/17/12

Trade WPI
NOW!

Partner Headlines

Watson Settles Patent Dispute - Analyst Blog 2/10/12

Momenta Badly Missing Q4 Forecasts On Lower Sales 2/9/12

Amgen Upped to Outperform - Analyst Blog 2/8/12

Shire and Sangamo Cut a Deal - Analyst Blog 2/7/12

Top 5 Small-Cap Drug Firms Include Questcor, Cubist 2/3/12

Watson in an Upbeat Mood - Analyst Blog 1/30/12

Gilead, Celgene Join Big Pharma On M&A Front 1/27/12

Momenta Pharmaceuticals 1/26/12

Momenta Plunges As Lovenox Fight Tilts Toward Watson 1/26/12

Watson's Impressive Prelim Results - Analyst Blog 1/25/12

Watson Buys Ascent Pharmahealth - Analyst Blog 1/24/12

Watson's Drug Fails to Get Support - Analyst Blog 1/23/12

Press Releases

Watson Confirms Beyaz(R) Patent Challenge 2/10/12 Newswire Story

Acorda Therapeutics Announces Launch of Authorized Generic Version of ZANAFLEX CAPSULES® 2/6/12 Business Wire Story

Watson Provides Update on Generic Lidoderm® Application 2/3/12 Newswire Story

Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2011 Earnings 1/30/12 Newswire Story

Watson Announces New Jersey-Based Global R&D Technology Center 1/30/12 Newswire Story

Watson Reaches Settlement with Mallinckrodt Over Exalgo(R) 1/27/12 Newswire Story

Watson Confirms Court Stays Preliminary Injunction 1/27/12 Newswire Story

Storage Network Advantage (SNA) & SiteLink Partner to Launch Collections Manager Software 1/25/12 PRWeb Story

Watson Announces Preliminary 2011 Non-GAAP Earnings of $4.75-$4.77 1/24/12 Newswire Story

Watson Acquires Ascent Pharmahealth for AU$375 Million 1/24/12 Newswire Story

FDA Advisory Committee Declines to Recommend Approval of Progesterone Vaginal Gel 8% for the Reduction of Risk of Preterm Birth in Women with Short Uterine Cervical Length 1/20/12 Newswire Story

Watson Launches Generic Yaz(R) 1/18/12 Newswire Story

Get the latest WPI stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Watson Pharmaceuticals, Inc. stock price.

Watson Pharmaceuticals, Inc. by YCharts